We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.02 (11.111%)
Open: 0.19
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Sep 2018 10:09

RNS Number : 3235C
Nuformix PLC
28 September 2018
 

 

28 Setember 2018

Nuformix plc

("Nuformix" or the "Company")

 

PDMR

 

The Company was notified on 28 September 2018 that Kirk Siderman-Wolter, Non-Executive Director of the Company, bought 35,364 Nuformix plc ordinary shares of 0.1p each ("Shares") at a purchase price of 2.6p per share.

 

Following this transaction he holds 35,364 shares, representing 0.00077% of the issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities.

 

a)

 

Name

 

 

Kirk  Siderman-Wolter

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Nuformix plc

b)

 

LEI

 

 

2138003XG3H3I2J3BJ24

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BYW79Y38

b)

 

Nature of the transaction

 

 

Acquisition of ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

2.6p

35,364

d)

 

Aggregated information

- Aggregated volume

35,364

- Price

2.6p

e)

 

Date of the transaction

 

 

16.08.18

f)

 

Place of the transaction

 

 

Standard List, London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGURUBUPRUBR
Date   Source Headline
14th Sep 20187:00 amRNSNXP001 Pre-Clinical Milestone Achieved
28th Aug 201812:55 pmRNSConvertible Loan Amendment
16th Aug 20187:00 amRNSAnnual Report and Notice of AGM
26th Jul 20182:00 pmRNSFinal Results
9th Jul 20189:33 amRNSHolding(s) in Company
2nd Jul 20187:00 amRNSOperational Update
26th Jun 20188:00 amRNSCollaboration with SGSC
11th May 20187:00 amRNSDr Chris Blackwell Appointed NED
24th Apr 201811:54 amRNSHolding(s) in Company
11th Apr 20184:41 pmRNSStmnt re Share Price Movement
2nd Mar 20181:30 pmRNSUpdate re: Broker
27th Feb 20189:37 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSNXP002 Pilot Study in Lung and Liver Fibrosis
15th Dec 20177:30 amRNSAgreement to License NXP001
14th Dec 20177:00 amRNSDr Andy Richards Chairs Advisory Panel - New Appts
12th Dec 20174:40 pmRNSSecond Price Monitoring Extn
12th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20177:00 amRNSGrant of Warrants
1st Dec 20177:30 amRNSAppointment of Broker
10th Nov 201710:19 amRNSHolding(s) in Company
1st Nov 201712:23 pmRNSHolding(s) in Company
23rd Oct 20177:30 amRNSHolding(s) in Company
19th Oct 20177:00 amRNSNXP001 agreement for pilot bioequivalence study
16th Oct 20177:00 amRNSAdmission and First Dealings
16th Oct 20177:00 amRNSCancellation Notice and Re-Admission
13th Oct 20173:44 pmRNSChange of Name
13th Oct 201712:35 pmRNSResult of Meeting and Completion of Acquisition
13th Oct 20177:00 amRNSHalf-year Report
22nd Sep 20177:00 amRNSFinal Results and Annual Report
15th Sep 20172:15 pmRNSProspectus re: Proposed Acquisition of Nuformix
20th Apr 20177:00 amRNSConvertible Loan Agreement
23rd Dec 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSAccounts for the period ended 31 March 2016
21st Sep 20167:00 amRNSNew Accounting Ref Date
16th Sep 20161:03 pmRNSPossible Acquisition and Suspension of Trading
29th Mar 20167:00 amRNSHalf Yearly Report
24th Feb 20167:00 amRNSBroker Appointment and Corporate Update
17th Dec 20157:00 amRNSPublication of Prospectus and First Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.